Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 56 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2009-02-04 4 S $8.01 $9,233,914 I/I (1,106,246) 6,896,530 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-05-22 4 B $5.64 $6,466,046 I/I 1,146,462 8,002,776 1.5 -
GEVA Synageva BioPharma Corp Director   –       •       •   2006-04-25 4 D $0.00 $0 I/I (1,228,857) 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2006-04-25 4 A $0.00 $0 I/I 1,228,857 1,228,857 -
GEVA Synageva BioPharma Corp Director   –       •       •   2011-11-02 4 A $0.00 $0 I/I 1,297,873 1,548,489 0 -
SGEN Seagen Inc Director   –       •      –    2006-06-09 4 B $4.00 $5,794,759 I/I 1,447,207 2,962,250 2.1 -
SGEN Seagen Inc Director   –       •       •   2009-08-11 4 B $10.75 $16,798,638 I/I 1,562,664 10,246,673 2.25 -
SGEN Seagen Inc Director   –       •       •   2007-02-14 4 S $8.72 $13,950,186 I/I (1,599,792) 3,474,819 0 -
SGEN Seagen Inc Director   –       •       •   2011-02-02 4 B $15.50 $27,152,947 I/I 1,751,803 13,470,692 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2015-06-22 4 D $0.00 $0 I/I (1,807,724) 12,250 0 -
TPPHQ Tapestry Pharmaceuticals ... 10% Owner   –       –       •   2008-10-15 4 S $0.00 $1,821 I/I (1,821,429) 0 0 -
SGEN Seagen Inc Director   –       •       •   2007-07-09 4 A $0.00 $0 I/I 1,916,150 5,390,969 0 -
SGEN Seagen Inc Director   –       •       •   2008-01-18 4 B $9.00 $17,400,807 I/I 1,933,423 7,326,145 2.25 -
SGEN Seagen Inc Director   –       •       •   2007-07-09 4 A $0.00 $0 I/I 2,101,300 3,254,517 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-01-29 4 B $6.00 $14,045,868 I/I 2,340,978 6,828,897 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-08-12 4 S $5.00 $18,315,817 I/I (3,645,600) 9,762,823 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2011-11-02 4 A $0.00 $0 I/I 3,749,926 4,000,451 0 -
SGEN Seagen Inc Director   –       •       •   2018-02-01 4 B $52.00 $199,999,956 I/I 3,846,153 44,355,335 2.25 -
XOMA XOMA Corporation Director   –       •       •   2012-10-29 4 B $3.00 $14,167,998 I/I 4,722,666 463,839 2.25 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2006-04-25 4 D $0.00 $0 I/I (6,580,168) 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2006-04-25 4 A $0.00 $0 I/I 6,580,168 11,175,900 -
ADLR Adolor Corp 10% Owner   –       –       •   2011-12-19 4 D $4.25 $28,344,687 I/I (6,669,338) 0 0 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56     
  Page 56 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us